Sarah C Haynes1,2, Tejaswi Kompala3, Aaron Neinstein3,4, Jennifer Rosenthal1,2, Stephanie Crossen1,2. 1. Department of Pediatrics, University of California, Davis, CA, USA. 2. Center for Health and Technology, University of California, Davis, CA, USA. 3. Department of Medicine, University of California, San Francisco, CA, USA. 4. Center for Digital Health Innovation, University of California, San Francisco, CA, USA.
Abstract
BACKGROUND: During the COVID-19 pandemic, telemedicine use rapidly and dramatically increased for management of diabetes mellitus. It is unknown whether access to telemedicine care has been equitable during this time. This study aimed to identify patient-level factors associated with adoption of telemedicine for subspecialty diabetes care during the pandemic. METHODS: We conducted an explanatory sequential mixed-methods study using data from a single academic medical center. We used multivariate logistic regression to explore associations between telemedicine use and demographic factors for patients receiving subspecialty diabetes care between March 19 and June 30, 2020. We then surveyed a sample of patients who received in-person care to understand why these patients did not use telemedicine. RESULTS: Among 1292 patients who received subspecialty diabetes care during the study period, those over age 65 were less likely to use telemedicine (OR: 0.34, 95% CI: 0.22-0.52, P < .001), as were patients with a primary language other than English (OR: 0.53, 95% CI: 0.31-0.91, P = .02), and patients with public insurance (OR: 0.64, 95% CI: 0.49-0.84, P = .001). Perceived quality of care and technological barriers were the most common reasons cited for choosing in-person care during the pandemic. CONCLUSIONS: Our findings suggest that, amidst the COVID-19 pandemic, there have been disparities in telemedicine use by age, language, and insurance for patients with diabetes mellitus. We anticipate telemedicine will continue to be an important care modality for chronic conditions in the years ahead. Significant work must therefore be done to ensure that telemedicine services do not introduce or widen population health disparities.
BACKGROUND: During the COVID-19 pandemic, telemedicine use rapidly and dramatically increased for management of diabetes mellitus. It is unknown whether access to telemedicine care has been equitable during this time. This study aimed to identify patient-level factors associated with adoption of telemedicine for subspecialty diabetes care during the pandemic. METHODS: We conducted an explanatory sequential mixed-methods study using data from a single academic medical center. We used multivariate logistic regression to explore associations between telemedicine use and demographic factors for patients receiving subspecialty diabetes care between March 19 and June 30, 2020. We then surveyed a sample of patients who received in-person care to understand why these patients did not use telemedicine. RESULTS: Among 1292 patients who received subspecialty diabetes care during the study period, those over age 65 were less likely to use telemedicine (OR: 0.34, 95% CI: 0.22-0.52, P < .001), as were patients with a primary language other than English (OR: 0.53, 95% CI: 0.31-0.91, P = .02), and patients with public insurance (OR: 0.64, 95% CI: 0.49-0.84, P = .001). Perceived quality of care and technological barriers were the most common reasons cited for choosing in-person care during the pandemic. CONCLUSIONS: Our findings suggest that, amidst the COVID-19 pandemic, there have been disparities in telemedicine use by age, language, and insurance for patients with diabetes mellitus. We anticipate telemedicine will continue to be an important care modality for chronic conditions in the years ahead. Significant work must therefore be done to ensure that telemedicine services do not introduce or widen population health disparities.
Entities:
Keywords:
COVID-19; diabetes mellitus; health disparities; telemedicine
Authors: Thomas S Nesbitt; Madan Dharmar; Jana Katz-Bell; Gunnar Hartvigsen; James P Marcin Journal: Telemed J E Health Date: 2013-01-23 Impact factor: 3.536
Authors: Salvatore C Rametta; Sara E Fridinger; Alexander K Gonzalez; Julie Xian; Peter D Galer; Michael Kaufman; Marisa S Prelack; Uzma Sharif; Mark P Fitzgerald; Susan E Melamed; Marissa P Malcolm; Sudha Kilaru Kessler; Donna J Stephenson; Brenda L Banwell; Nicholas S Abend; Ingo Helbig Journal: Neurology Date: 2020-06-09 Impact factor: 9.910
Authors: Sarah C Haynes; Tejaswi Kompala; Daniel J Tancredi; Aaron B Neinstein; Stephanie S Crossen Journal: Diabetes Care Date: 2022-02-01 Impact factor: 19.112
Authors: Leigh Ann Simmons; Jennifer E Phipps; Mackenzie Whipps; Paige Smith; Kathryn A Carbajal; Courtney Overstreet; Jennifer McLaughlin; Koen De Lombaert; Devon Noonan Journal: Digit Health Date: 2022-09-25